Despite promising preclinical findings regarding the reduction in tumor growth through hormonal mechanisms, the clinical impact of GLP-1Ra on cancer outcomes, particularly in NEN, remains largely unexplored [17]
Researchers should approach this peptide with appropriate caution and rigorous experimental controls (Pickart & Margolina, 2018)
Founder of PHARMeMED | 2M+ Pharma & Life Sciences Network | Drug Development & Biotech Industry Analyst | Drug Development, Biotech, R&D, Medical Affairs & Clinical Research Lillys Next Big Move in Obesity & Diabetes: A Pill That Rivals Injectables Eli Lilly just dropped major Phase 3 results and they could reshape the weight-loss and diabetes market once again
Yes, we only treat patients 24 and older
Ready to explore whether GLP-1 therapy could improve your sleep
One possible issue is the formation of cysts, bumps, lumps, or skin irregularities in the treated area